About MedChemComm

MedChemComm is a new, peer-reviewed journal publishing medicinal chemistry research.

 

Co-Editors-in-Chief

Dr Anthony Wood, Pfizer, USA

Professor Greg Verdine, Harvard University, USA

 

Scope:

Medicinal chemistry, drug discovery, pharmacology and pharmaceutical research, including traditional areas of the chemical sciences together with topics at the interface with biology and physics. Examples of areas included within the journal's scope are:

-  Design, synthesis and biological evaluation of novel chemical or biochemical entities leading to new pharmacological agents, probes and/or potential drugs 

-  Computational, biophysical, physicochemical, molecular biological, proteomic studies of ch/bc entities and their interaction within their biological environment

-   Pharmacokinetic behaviour, pharmacodynamics, and drug safety and toxicology

-  Chemical biology studies that enable drug discovery 

-   Chemical modifications of known chemical or biochemical entities that improve pharmacological properties 

 

Article Types

Concise Article: For the presentation of new results. Generally between 3 and 7 journal pages in length.

Review: Critical reviews of key areas of medicinal chemistry research.

 

Author Benefits

* Fast publication

* Free colour online (and in print where it enhances scientific understanding)

* Worldwide readership

* Top articles publicised in the wider scientific media

Partner Society
MedChemComm is the official journal of the European Federation for Medicinal Chemistry (EFMC).

About the partner society

The European Federation for Medicinal Chemistry (EFMC), founded in 1972, represents 23 scientific organisations from 21 European countries. Its objective is to advance the science of medicinal chemistry by promoting cooperation and encouraging contacts and exchanges between medicinal chemists in Europe and around the World. Important activities of the EFMC comprise the organisation of international scientific meetings and short courses, the sponsorship of medicinal chemistry schools, and the publication of MedChemWatch. The EFMC also acknowledges the excellence of medicinal chemists' work by conferring three major awards: the Nauta Award on Pharmacochemistry, the UCB - Ehrlich Award for Excellence in Medicinal Chemistry and the Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery.